Shi GP - Search Results

1

Cathepsin S activity controls chronic stress-induced muscle atrophy and dysfunction in mice.

Wan Y, Piao L, Xu S, Meng X, Huang Z, Inoue A, Wang H, Yue X, Jin X, Nan Y, Shi GP, Murohara T, Umegaki H, Kuzuya M, Cheng XW. Wan Y, et al. Among authors: shi gp. Cell Mol Life Sci. 2023 Aug 17;80(9):254. doi: 10.1007/s00018-023-04888-4. Cell Mol Life Sci. 2023. PMID: 37589754 Free PMC article.

2

Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries.

Cheng XW, Kuzuya M, Sasaki T, Arakawa K, Kanda S, Sumi D, Koike T, Maeda K, Tamaya-Mori N, Shi GP, Saito N, Iguchi A. Cheng XW, et al. Among authors: shi gp. Am J Pathol. 2004 Jan;164(1):243-51. doi: 10.1016/S0002-9440(10)63114-8. Am J Pathol. 2004. PMID: 14695337 Free PMC article.

3

Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3.

Cheng XW, Kuzuya M, Nakamura K, Di Q, Liu Z, Sasaki T, Kanda S, Jin H, Shi GP, Murohara T, Yokota M, Iguchi A. Cheng XW, et al. Among authors: shi gp. Am J Pathol. 2006 Feb;168(2):685-94. doi: 10.2353/ajpath.2006.050295. Am J Pathol. 2006. PMID: 16436681 Free PMC article.

4

Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure.

Cheng XW, Obata K, Kuzuya M, Izawa H, Nakamura K, Asai E, Nagasaka T, Saka M, Kimata T, Noda A, Nagata K, Jin H, Shi GP, Iguchi A, Murohara T, Yokota M. Cheng XW, et al. Among authors: shi gp. Hypertension. 2006 Nov;48(5):979-87. doi: 10.1161/01.HYP.0000242331.99369.2f. Epub 2006 Sep 18. Hypertension. 2006. PMID: 16982960

5

Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment.

Cheng XW, Murohara T, Kuzuya M, Izawa H, Sasaki T, Obata K, Nagata K, Nishizawa T, Kobayashi M, Yamada T, Kim W, Sato K, Shi GP, Okumura K, Yokota M. Cheng XW, et al. Among authors: shi gp. Am J Pathol. 2008 Aug;173(2):358-69. doi: 10.2353/ajpath.2008.071126. Epub 2008 Jun 26. Am J Pathol. 2008. PMID: 18583318 Free PMC article.

6

Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers.

Cheng XW, Okumura K, Kuzuya M, Jin Z, Nagata K, Obata K, Inoue A, Hirashiki A, Takeshita K, Unno K, Harada K, Shi GP, Yokota M, Murohara T. Cheng XW, et al. Among authors: shi gp. J Cardiovasc Pharmacol. 2009 Jul;54(1):47-56. doi: 10.1097/FJC.0b013e3181ab371d. J Cardiovasc Pharmacol. 2009. PMID: 19528815 Free PMC article.

7

Ca(2+) channel blocker benidipine promotes coronary angiogenesis and reduces both left-ventricular diastolic stiffness and mortality in hypertensive rats.

Nishizawa T, Cheng XW, Jin Z, Obata K, Nagata K, Hirashiki A, Sasaki T, Noda A, Takeshita K, Izawa H, Shi GP, Kuzuya M, Okumura K, Murohara T. Nishizawa T, et al. Among authors: shi gp. J Hypertens. 2010 Jul;28(7):1515-26. doi: 10.1097/HJH.0b013e328339fd3a. J Hypertens. 2010. PMID: 20543715 Free PMC article.

8

Exercise training stimulates ischemia-induced neovascularization via phosphatidylinositol 3-kinase/Akt-dependent hypoxia-induced factor-1 alpha reactivation in mice of advanced age.

Cheng XW, Kuzuya M, Kim W, Song H, Hu L, Inoue A, Nakamura K, Di Q, Sasaki T, Tsuzuki M, Shi GP, Okumura K, Murohara T. Cheng XW, et al. Among authors: shi gp. Circulation. 2010 Aug 17;122(7):707-16. doi: 10.1161/CIRCULATIONAHA.109.909218. Epub 2010 Aug 2. Circulation. 2010. PMID: 20679550 Free PMC article.

9

Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin.

Cheng XW, Kuzuya M, Sasaki T, Inoue A, Hu L, Song H, Huang Z, Li P, Takeshita K, Hirashiki A, Sato K, Shi GP, Okumura K, Murohara T. Cheng XW, et al. Among authors: shi gp. J Hypertens. 2011 Mar;29(3):542-52. doi: 10.1097/HJH.0b013e328341cedf. J Hypertens. 2011. PMID: 21119529 Free PMC article.

10

Angiotensin type 1 receptor blocker reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

Cheng XW, Song H, Sasaki T, Hu L, Inoue A, Bando YK, Shi GP, Kuzuya M, Okumura K, Murohara T. Cheng XW, et al. Among authors: shi gp. Hypertension. 2011 May;57(5):981-9. doi: 10.1161/HYPERTENSIONAHA.110.168385. Epub 2011 Apr 4. Hypertension. 2011. PMID: 21464389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page